185 related articles for article (PubMed ID: 9000091)
21. C58 and AKR mice of all ages develop motor neuron disease after lactate dehydrogenase-elevating virus infection but only if antiviral immune responses are blocked by chemical or genetic means or as a result of old age.
Anderson GW; Even C; Rowland RR; Palmer GA; Harty JT; Plagemann PG
J Neurovirol; 1995 Sep; 1(3-4):244-52. PubMed ID: 9222362
[TBL] [Abstract][Full Text] [Related]
22. Ia antigens and Fc receptors of mouse peritoneal macrophages as determinants of susceptibility to lactic dehydrogenase virus.
Inada T; Mims CA
J Gen Virol; 1985 Jul; 66 ( Pt 7)():1469-77. PubMed ID: 3860626
[TBL] [Abstract][Full Text] [Related]
23. Neuropathogenicity and sensitivity to antibody neutralization of lactate dehydrogenase-elevating virus are determined by polylactosaminoglycan chains on the primary envelope glycoprotein.
Chen Z; Li K; Plagemann PG
Virology; 2000 Jan; 266(1):88-98. PubMed ID: 10612663
[TBL] [Abstract][Full Text] [Related]
24. Immune response to lactate dehydrogenase-elevating virus: isolation of infectious virus-immunoglobulin G complexes and quantitation of specific antiviral immunoglobulin G response in wild-type and nude mice.
Cafruny WA; Plagemann PG
Infect Immun; 1982 Sep; 37(3):1001-6. PubMed ID: 7129626
[TBL] [Abstract][Full Text] [Related]
25. Replication of lactate dehydrogenase-elevating virus in cells infected with murine leukaemia viruses in vitro.
Inada T; Yamazaki S
J Gen Virol; 1991 Oct; 72 ( Pt 10)():2437-44. PubMed ID: 1655956
[TBL] [Abstract][Full Text] [Related]
26. Production of virus-specific antiserum corresponding to sequences in the lactate dehydrogenase-elevating virus (LDV) ORF6 protein.
Takahashi-Omoe H; Omoe K; Sakaguchi M; Kameoka Y; Matsushita S; Inada T
Comp Immunol Microbiol Infect Dis; 2004 Jan; 27(1):47-55. PubMed ID: 14656541
[TBL] [Abstract][Full Text] [Related]
27. Differential anti-Golgi complex autoantibody production following murine lactate dehydrogenase-elevating virus infection.
Nozawa K; Fritzler MJ; Ikeda K; Takasaki Y; Satoh M; Chan EK
Immunopharmacol Immunotoxicol; 2008; 30(1):13-25. PubMed ID: 18306101
[TBL] [Abstract][Full Text] [Related]
28. Lactate dehydrogenase-elevating virus infection at the sensitization and challenge phases reduces the development of delayed eosinophilic allergic rhinitis in BALB/c mice.
Sasaki Y; Hayashi T; Hasegawa K
Scand J Immunol; 2007 Dec; 66(6):628-35. PubMed ID: 17949409
[TBL] [Abstract][Full Text] [Related]
29. Selective antibody neutralization prevents neuropathogenic lactate dehydrogenase-elevating virus from causing paralytic disease in immunocompetent mice.
Chen Z; Li K; Rowland RR; Plagemann PG
J Neurovirol; 1999 Apr; 5(2):200-8. PubMed ID: 10321985
[TBL] [Abstract][Full Text] [Related]
30. Lactate dehydrogenase-elevating virus (LDV): lifelong coexistence of virus and LDV-specific immunity.
van den Broek MF; Spörri R; Even C; Plagemann PG; Hänseler E; Hengartner H; Zinkernagel RM
J Immunol; 1997 Aug; 159(4):1585-8. PubMed ID: 9257815
[TBL] [Abstract][Full Text] [Related]
31. Replication competition between lactate dehydrogenase-elevating virus quasispecies in mice. Implications for quasispecies selection and evolution.
Plagemann PG; Chen Z; Li K
Arch Virol; 2001 Jul; 146(7):1283-96. PubMed ID: 11556706
[TBL] [Abstract][Full Text] [Related]
32. Hydrophobic IgG-containing immune complexes in the plasma of autoimmune MRL/lpr mice, lactate dehydrogenase-elevating virus-infected mice, and pigs: association with transforming growth factor-beta and pH-dependent amplification.
Zitterkopf NL; Jones QA; Bradley DS; Durick K; Rowland RR; Plagemann PG; Cafruny WA
Viral Immunol; 2003; 16(4):511-23. PubMed ID: 14733738
[TBL] [Abstract][Full Text] [Related]
33. Lactate dehydrogenase-elevating virus induces antibodies reactive with a surface antigen of aetiologically unrelated murine cell transformants.
Weiland E; Grossmann A; Thiel HJ; Weiland F
J Gen Virol; 1990 May; 71 ( Pt 5)():1233-6. PubMed ID: 2345370
[TBL] [Abstract][Full Text] [Related]
34. Divergent roles of IFNs in the sensitization to endotoxin shock by lactate dehydrogenase-elevating virus.
Le-Thi-Phuong T; Dumoutier L; Renauld JC; Van Snick J; Coutelier JP
Int Immunol; 2007 Nov; 19(11):1303-11. PubMed ID: 17914119
[TBL] [Abstract][Full Text] [Related]
35. Immunoglobulin transfer from immune-reconstituted SCID mice to nursing neonates: blood distribution of antibody and association with perinatal virus protection.
Broen JJ; Cafruny WA
Reg Immunol; 1993; 5(1):44-52. PubMed ID: 8347469
[TBL] [Abstract][Full Text] [Related]
36. Blocking of cell-mediated immunity to Moloney murine sarcoma virus-transformed cells by lactate dehydrogenase virus-antibody complex.
McDonald TL
J Natl Cancer Inst; 1983 Mar; 70(3):493-7. PubMed ID: 6572738
[TBL] [Abstract][Full Text] [Related]
37. Lactate dehydrogenase-elevating virus entry into the central nervous system and replication in anterior horn neurons.
Anderson GW; Palmer GA; Rowland RR; Even C; Plagemann PG
J Gen Virol; 1995 Mar; 76 ( Pt 3)():581-92. PubMed ID: 7897349
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-6 production by macrophages from BALB/c mice with a chronic infection of lactic dehydrogenase virus.
Iwata H; Hayashi T
Jikken Dobutsu; 1994 Oct; 43(4):559-62. PubMed ID: 7805801
[TBL] [Abstract][Full Text] [Related]
39. Live lactate dehydrogenase-elevating virus (LDV) induces suppressor T cells that inhibit the development of delayed hypersensitivity to LDV.
Inada T; Mims CA
J Gen Virol; 1986 Oct; 67 ( Pt 10)():2103-12. PubMed ID: 2944991
[TBL] [Abstract][Full Text] [Related]
40. Replication of lactate dehydrogenase-elevating virus in macrophages. 1. Evidence for cytocidal replication.
Ritzi DM; Holth M; Smith MS; Swart WJ; Cafruny WA; Plagemann GW; Stueckemann JA
J Gen Virol; 1982 Apr; 59(Pt 2):245-62. PubMed ID: 7077301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
